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Background. Despite the fact that urea kinetic modelling has
been successfully applied to quantify the hemodialysis since the
beginning of the 1980s, there is not a consensus yet concerning
which is the most proper dialysis dose index and the method for
calculating it. In this work, we propose that a combined mea-
surement of the dialysis dose from two complementary perspec-
tives of the removal process should provide a more complete
description of dialysis than a measurement alone. This hypo-
thesis is reviewed and the measuring methods are compared.
Methods. A cross-sectional randomized clinical study over
98 stable ESRD patients submitted to thrice-weekly hemodial-
ysis was carried out with the aim of comparing 16 blood-side
methods for measuring the hemodialysis dose from patient and
dialyzer perspectives. The availability of urea rebound mea-
surements and computational resources have been taken into
account.
Results. The outcomes point to four novel blood-side methods
as the most accurate for measuring the effective dialysis system
Kt/V (mKt/V) in clinical conditions. Their limits of agreement
(mean ± 2·SD) range from 1.93 ± 2.09% for a non-iterative
method without the urea rebound measurement (BUN3 ) to
−0.08 ± 0.58% for an iterative method with BUN3 . The best
non-iterative blood-side method for measuring the equilibrated
Kt/V (eKt/V) is the second generation formula of Daugirdas
(−2.42 ± 1.05%) when BUN3 is available and the rate equation
of Daugirdas and Schneditz (−1.74 ± 7.91%) when BUN3 is
not available. The difference mKt/V−eKt/V is significant and
positive, and increases with the dialysis dose in a personalized
manner.
Conclusion. We have confirmed the arguments that support
the hypothesis of the study. The best blood-side methods for
the combined measurement of dialysis dose as a function of the
available resources have been determined.
Data obtained from the National Cooperative Dial-
ysis Study (NCDS) indicated that increased morbidity
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seemed to be associated with relatively high blood urea
nitrogen (BUN) concentration in end-stage renal disease
(ESRD) patients submitted to thrice-weekly hemodial-
ysis (HD) [1, 2]. However, the role of the dietary pro-
tein intake, taken as the normalized protein catabolic rate
(NPCR), was unclear because patients with NPCR below
0.8 g/kg/day had a high probability of failure irrespective
of BUN level.
This paradox was partly solved when the NCDS data
were reanalyzed in a subsequent study performed by
Gotch and Sargent [3]. This work discovered a relation-
ship between the relative risk of mortality (RR) and
the index Kt/V. The latter was defined as the product
km·T/VT, where km is the effective dialysis system urea
clearance, T is the dialysis session duration, and VT is the
patient urea distribution volume at the end of the session.
The cited relationship justifies that Kt/V was considered
a measurement of the HD dose. The Kt/V was calcu-
lated using the single-pool urea kinetic model (spUKM),
which assumes that urea is homogenously distributed.
However, urea distribution is more complicated, and it
takes a time for urea to equilibrate from the muscle cell
pool to plasma water after dialysis session is ended. So
the use of spUKM causes a deviation between the previ-
ous target value, km·T/VT, and the Kt/V calculated from
it. With the aim of distinguishing both indices along the
present study, the Kt/V obtained with the spUKM under
the approach of the NCDS study is denoted as spKt/V
(single-pool Kt/V), whereas the product km·T/VT is de-
noted as mKt/V (effective dialysis system Kt/V).
Certainly, it is now widely accepted that spKt/V is only
one among many other factors to be considered in the
ESRD patient therapy. Moreover, there are some criti-
cisms regarding the use of spKt/V and other Kt/V variants
to quantify the adequacy of dialysis [4, 5]. Notwithstand-
ing, the validity of Kt/V as a measurement of dialysis
dose and dialysis adequacy is recognized and supported
by many observational and interventional studies after
the NCDS [6–8], as well as review studies [9, 10]. In agree-
ment with this, several Kt/V-based indices (e.g., spKt/V)
are advised currently by the K/DOQI guidelines for quan-
tifying the dialysis dose [11].
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Several comparative clinical studies were carried out
to find the more accurate method for approximating the
Kt/V provided by the spUKM, concluding that the second
generation formula of Daugirdas [12] is the most accurate
[13, 14].
The difference between spKt/V and mKt/V is associ-
ated to the distributed nature of urea kinetic and, hence,
increases with the urea clearance delivered during HD,
and is related to the urea rebound for 30 to 60 minutes
after dialysis. Two kinds of approaches have been devel-
oped to avoid this problem. The first of them tries to
reduce the difference between the measured Kt/V and
the true mKt/V using a two-pool a urea kinetic model
(2pUKM) for predicting the evolution of extracellular
urea concentration during dialysis. Despite the high ac-
curacy of this approach, it is difficult to implement in clin-
ical due to the excessive computational complexity and
the intersession variation of the patient two-pool kinetic
parameters [15, 16].
The second approach is based on the selection of a dif-
ferent target Kt/V. This is defined as ek·T/VT, where ek is
the clearance needed to remove from a well-stirred pool
with volume VT, and during a time equal to the session
duration, T, the same urea mass removed from the pa-
tient. This Kt/V is called eKt/V (equilibrated Kt/V), and
according to the definition it is independent of the urea
rebound. It can be calculated from the spUKM, substi-
tuting the postdialysis blood urea nitrogen concentration,
BUN2, by the blood urea nitrogen concentration 30 to
60 minutes after dialysis, BUN3 [17].
The eKt/V is directly related to the normalized urea
removal that can be measured by the direct dialysis quan-
tification (DDQ) method, which has been considered the
gold standard since the 1980s, according to its accuracy
[18, 19]. Despite that other dialysate-side modified tech-
niques less costly and complex than DDQ have been de-
veloped [20, 21], the cited blood-side spUKM method
is preferable in clinical practice because it provides the
same accuracy [22].
An important problem of the eKt/V is that the patient
is compelled to wait 30 to 45 minutes after the end of dial-
ysis. Three types of techniques were designed to estimate
the eKt/V without BUN3. The first of them estimates the
urea rebound by intradialytic blood samples [23–26]. A
second method is based on the correction of the spKt/V by
the urea kinetic rate constant, k/V = (spKt/V)/T [27, 28].
The third approach corrects the spKt/V with the physio-
logically appropriate patient clearance time (tp), which is
the time needed to clear all the body pools when dialyzer
clearance is infinite [29].
However, despite that urea kinetic modelling has been
successfully applied to quantify the hemodialysis since
the beginning of 1980s, there is not a consensus yet con-
cerning what is the most proper dialysis dose index and
the method for calculating it. In this sense, we should
consider that eKt/V and mKt/V provide two complemen-
tary perspectives of the removal process, which are the
point of view of the patient and the point of view of the
dialysis system, respectively. This concept is illustrated
in Figure 1. As commented in the figure legend, each
diagram is related to a point of measurement, which is
defined by the kinetic mechanisms that are considered
when the urea clearance is measured. The choice of a
point of view can be performed by means of the time
that goes by from the end of dialysis to the postdialysis
blood extraction instant. By this manner, the clearance
ek is associated with diagram (d), whereas the clearance
km is associated to diagrams (a), (b), or (c), if that time
is approximately equal to 0 (km = kds), 20 seconds (km =
kAR ds), and 2 minutes (km = kAR,CPR ds), respectively
[17, 30].
Accordingly, a combined measurement of eKt/V and
mKt/V should provide a more complete description of
the dialysis process than the eKt/V alone. This hypothesis
is supported by several arguments. First, the index vali-
dated by the NCDS and many subsequent clinical studies
is the spKt/V [3, 6, 7], which is closer to mKt/V than eKt/V
[31]. Second, the difference mKt/V–eKt/V carries infor-
mation about the weight of the mechanisms involved in
urea disequilibrium, as shown in Figure 1 [31]. Their rela-
tive weight may be discriminated by drawing blood sam-
ples at 0 seconds, 20 seconds, and 2 minutes after the end
of the session, as a function of the type of vascular access.
In addition, as the causal mechanisms associated to the
relationship RR—spKt/V are not known, the knowledge
about the removal of other uremic toxins that may be
extracted from the difference urea eKt/V–urea mKt/V,
thanks to the information that this difference provides
about the mechanisms involved in the disequilibrium of
solutes through the body pools, could throw light on this
issue.
The methods currently exploited in clinical for assisting
nephrologists to select the dialyzer membrane use neglect
the difference between mKt/V and spKt/V, which is asso-
ciated to the distributed character of urea. We can cite the
method presented in Daugirdas et al [30] as an example.
However, the nephrologists need to know what value of
kds (Fig. 1A) is associated to the dialysis dose prescribed
to a particular patient, eKt/V (Fig. 1D). This issue gives
another application of the combined use of eKt/V and
mKt/V. The preliminary outcomes of a new technique
based on the relationship eK/V–mKt/V that assists the
physician on the selection of the dialyzer membrane have
been already published [32].
In this work, we analyze the accuracy of the best dif-
ferent methods for calculating mKt/V and eKt/V, con-
sidering the availability of computational resources and
BUN3. We have restricted to blood-side single-pool
methods attending to their proper performance in clini-
cal environments, as described above. The study has been
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Fig. 1. Block diagram that shows the mechanisms involved in patient urea kinetic, together with their approximated time of influence after the
end of dialysis (left vertical axis). As indicated, the distribution of urea is deviated from the homogeneous state given by the well-stirred pool by
three major mechanisms. Compartmental barriers and blood perfusion have the highest influence in the urea disequilibrium. Cardiopulmonary
recirculation has influence in arterial vascular accesses. Access recirculation should be smaller than 5% to 15% in a healthy vascular access, and
it needs to be controlled. The area bounded by dashed lines shows the point from which the urea clearance is measured. Diagram (A) shows the
point of view of the dialysis system and, hence, gives the dialysis system clearance, kds. Diagram (D) extracts all the mechanisms associated to the
urea disequilibrium from the point of measurement, giving the equilibrated clearance, ek. Intermediate diagrams (B and C) provide two effective
dialysis system clearances, kARds (access recirculation extracted) and k
AR,CPR
ds (access recirculation plus cardiopulmonary recirculation extracted).
carried out over 98 stable ESRD patients submitted to pe-
riodic HD. The Methods section has been organized into
three subsections that present the clinical procedures, the
methods used for measuring the reference indices, mKt/V
and eKt/V and, finally, the evaluated HD dose measure-
ment methods. The Results section has been organized
in two parts according to the Kt/V used as target, mKt/V
or eKt/V.
METHODS
Clinical study
We have performed a cross-sectional comparative
study over 98 stable ESRD patients submitted to thrice-
weekly HD (Monday, Wednesday, and Friday), randomly
selected. Seventy-three patients were anuric, and the oth-
ers were oliguric. All of them used distal radiocephalic
fistulas as vascular access. The access recirculation (AR)
was below 20% in all of the patients, with the exception
of two of them that presented 27% and 30%. AR mea-
surements were performed by the two-needle urea-based
method [33]. We measured BUN concentrations at pre-
dialysis (BUN1), postdialysis (BUN2), and 30 minutes af-
ter the end of the HD session (BUN3), for the Wednesday
session in all of the patients. Sessions were classified in
three groups. The first was constituted by 30 sessions de-
livered to 30 anuric patients, whose BUN2 was sampled
1 minute after the end of the session (s = 1 min), keeping
a low blood flow (50 mL/min) in the dialyzer arterial line.
The second group was constituted by 43 sessions deliv-
ered to the remaining 43 anuric patients, whose BUN2
was sampled 2 minutes after the end of the session (s =
2 min), under the same standard procedure than the first
group. The third group was defined by the HD sessions
of patients with residual diuresis. The value of BUN2 was
taken as in the second group. The effective dialysis sys-
tem urea clearance has been taken as km = kAR,CPR ds in
this study (Fig. 1C), according to the value of s .
The organization of patients in three groups was
performed to study the sensitivity of methods to the
intergroup variation, to the influence of diuresis, and to
variations of the postdialysis extraction instant, s . This
group-based methodology has been used successfully in
other clinical works for assessing the influence of in-
tergroup parameter differences on the accuracy of the
method studied [34, 35].
The dialysate flow rate was 500 mL/min in all of the ses-
sions. The operating conditions were kept constant dur-
ing each session. The major clinical and anthropometrical
parameters for each group are summarized in Table 1.
The value of the glomerular filtration rate (GFR) in
the third group was measured according to data by Mi-
lutinovic et al [36]. The renal residual urea clearance, Kur,
was computed using Equation 1, where UFR is the urea
flow rate [37]. All flow rates in Equation 1 are in mL/min.
Kur = 0.57 · GFR · e0.36·UFR (1)
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Table 1. Mean ± SD (range) of major clinical and anthropometric parameters for the three groups of the study
Clinical parameter Group 1 Group 2 Group 3
Age years 56.4 ± 14.0 (22–71) 53.2 ± 12.8 (24–70) 42.2 ± 15.4 (20–69)
Body weight kg 68.5 ± 15.7 (43–123) 65.4 ± 11.0 (51.1–98) 67.8 ± 14.8 (47.3–121.5)
Ultrafiltration volume mL 2147 ± 1164 (0–4600) 2156 ± 736 (100–4400) 1948 ± 915 (400–3700)
Session duration hours 4.0 ± 0.3 (3–4.5) 4.0 ± 0.3 (3.5–4.5) 3.8 ± 0.5 (3–5)
Urine volume mL/72 h – – 1064 ± 699 (10–2500)
GFR mL/min – – 2.8 ± 2.3 (0.18–8.11)
nPCR g/kg/day 0.9 ± 0.3 (0.5–1.8) 1.0 ± 0.2 (0.66–1.58) 1.0 ± 0.2 (0.69–1.29)
BUN1 mg/dL 67.4 ± 17.0 (34–123.2) 73.8 ± 14.7 (44.8–102.7) 71.7 ± 14.9 (45.3–112.5)
BUN2 mg/dL 21.6 ± 7.2 (10.7–40.6) 25.1 ± 8.3 (11.2–60.2) 26.7 ± 11.6 (13.1–70.5)
BUN3 mg/dL 25.2 ± 8.3 (11.7–47.6) 28 ± 8.8 (13.1–63.5) 29.5 ± 11.6 (15.4–72.8)
Gender men/women 12/18 26/17 13/12
Reference methods
The mKt/V reference value was measured by means
of the 2pUKM, which is described in the Appendix. This
model is an extension of the one of Canaud et al [15] for
taking into account the renal residual clearance. The high
accuracy of this model was verified by Canaud et al, com-
paring model extracellular urea concentrations to plasma
urea concentrations measured by a continuous urea mon-
itoring system (UMS) [15].
We have calculated the fraction of volume into the
extracellular compartment, fv1, the intercompartmental
mass-transfer coefficient, Kc, and the effective dialysis
system urea clearance, km, in each session, by fitting the
2pUKM extracellular urea nitrogen concentration, c1,
to the urea nitrogen concentration measured predialy-
sis, postdialysis, and 30 minutes (tequ) after the end of
dialysis, c1(0) = BUN1, c1(T) = BUN2, c1(T+ ttequ) =
BUN3, respectively. In addition, we considered that urea
recovers the equilibrium (homogeneous distribution) at
tf = T + tequ. This condition was implemented by mak-
ing c1(tf) equal to the urea nitrogen concentration in the
nonaccessible compartment, c2(tf) (see Appendix). The
value of mKt/V computed by this methodology is hardly
dependent on tf, and thus we can neglect small deviations
in mKt/V associated to the selected tf value [31].
The urea distribution volume at the end of dialysis,
VT, is an input to the 2pUKM. It was calculated by the
anthropometric formula from Watson et al [38], thanks to
the low sensitivity of the mKt/V obtained by the 2pUKM
to the errors of VT [31]. The urea distribution volume was
considered constant during the 30 minutes after until the
end of HD session.
The urea nitrogen generation rate, G, which is also re-
quired as input to the 2pUKM, was measured solving the
spUKM by means of the two-BUN method, in agreement
with the clinical stability of the patients selected for the
study, and taking BUN3 as boundary condition for t = T.
The mathematical procedure is described with detail in
the Appendix. The high accuracy of this indirect method
for measuring G has been verified in clinical and analyt-
ical studies [15, 31, 39].
The methodology that has been described for solving
the 2pUKM was previously justified and used in Prado
et al [31], with successful results. The fulfillment of the
cited boundary conditions with VT and G as inputs to
2pUKM allows detecting mistakes in blood samples, as
well as the validity of the periodicity condition associated
to the two-BUN method (see Appendix). This technique
captured 14 noncompliance ESRD patients who were dis-
carded from the initial 112 patients, to give the 98 patients
of the present study.
The eKt/V reference value was obtained by means of
the spUKM, using BUN3 as boundary condition, as pre-
viously described. The high accuracy of this measuring
method was verified by Bosticardo and Alloatti [22]. The
mathematical details are described in the Appendix.
The deviations mKt/V–eKt/V and mKt/V−spKt/V will
be presented with the aim of confirming the arguments
that support the combined use of mKt/V and eKt/V as
dialysis dose indices.
Evaluated methods
The selection of the best measurement method should
take into account the computational resources and blood
samples available. Table 2 presents the methods consid-
ered in this work, as well as the targets against these ones
are compared. The three first methods are iterative and,
hence, require computational resources to be solved. The
values of BUNs required to solve a method depend on
the target Kt/V, as shown. All the mathematical details
are described in the Appendix. Regarding the notation,
we have decided to name non-iterative methods accord-
ing to the first author that published them, whereas iter-
ative methods are called by acronyms. We indicate the
required BUNs after the formula name in methods that
can be used for measuring different target Kt/V indices.
For example, Daugirdas#1 (BUN1, BUN2) refers to the
second generation formula of Daugirdas used to estimate
spKt/V.
Among the non-iterative measurement methods, we
have considered the most important up to 1996 reviewed
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Table 2. Measuring methods assessed, together with their target Kt/V indices and required resources
Method Bibliographic source BUNs for mKt/V BUNs for eKt/V
spUKMa Sargent and Gotch [41] BUN1, BUN2 BUN1, BUN3
nspUKMa Prado et al [31] BUN1, BUN2, BUN3 –
nspUKM2ma Prado et al [31] BUN1, BUN2 –
Lowrie#1 Lowrie and Teehan [62] BUN1, BUN2 BUN1, BUN3
Jindal#1 Jindal [63] BUN1, BUN2 BUN1, BUN3
Barth#1 Barth [64] BUN1, BUN2 BUN1, BUN3
Calzavara#1 Calzavara et al [65] BUN1, BUN2 BUN1, BUN3
Keshaviah#1 Keshaviah et al [66] BUN1, BUN2 BUN1, BUN3
Basile#1 Basile et al [67] BUN1, BUN2 BUN1, BUN3
Ijely#1 Ijely and Raja [68] BUN1, BUN2 BUN1, BUN3
Kerr#1 Kerr et al [69] BUN1, BUN2 BUN1, BUN3
Daugirdas#1 Daugirdas [12] BUN1, BUN2 BUN1, BUN3
Prado#1 Prado et al [42] BUN1, BUN2, BUN3 –
Prado#2 Prado et al [42] BUN1, BUN2 –
Daugirdas#2 Daugirdas and Schneditz [27] – BUN1, BUN2
Tattersall#1 Tattersall et al [29] – BUN1, BUN2
aIterative method.
by Movilli [40], and subsequently evaluated in compar-
ative comparative study by Covic et al [13]. These are
Lowrie#1, Jindal#1, Barth#1, Calzavara#1, Keshaviah#1,
Basile#1, Ijely#1, Kerr#1, and Daugirdas#1. The latter
is usually known as the second generation formula of
Daugirdas, although we prefer to follow a homogeneous
nomenclature. The shortcut formulas collected in [40]
were developed for estimating the Kt/V computed by the
original single-pool urea kinetic model (spUKM) [41]. As
a consequence, they can estimate spKt/V and eKt/V with
similar accuracy, as solutions of spUKM, simply substi-
tuting BUN2 by BUN3, as shown in Table 2. Taking into
account that spKt/V may be considered a gross approx-
imation of mKt/V [31], those formulas have been com-
pared against mKt/V and eKt/V in this study.
We have added two recent non-iterative methods that
were developed to measure mKt/V when BUN3 is avail-
able (Prado#1) and when this BUN is not available
(Prado#2) [42]. However, these two methods cannot be
used to measure eKt/V.
None of the upper non-iterative methods can measure
the eKt/V if BUN3 is not available. To address this is-
sue, we have considered two of the three mathematical
approaches cited in the previously. These are the rate
equation of Daugirdas and Schneditz (Daugirdas#2) [27]
and the formula from Tattersall et al (Tattersall#1) [29].
Intradialytic blood samples methods for estimating the
urea rebound have not been considered in account of
their lesser accuracy [43–47]. We have also not consid-
ered the formula of Maduell et al [28], based on the urea
kinetic rate constant, k/V, despite that its accuracy is simi-
lar to that of Daugirdas#2, due to the latter, which is much
more extended.
The spKt/V index is an input to Daugirdas#2 and
Tattersall#1 formula. We have used an estimate of this
value, spKt/Vest , calculated by Daugirdas#1 (BUN1,
BUN2), according to the high accuracy of this simplified
method as an approximation of the solution provided by
the spUKM model. This accuracy will be confirmed in
this study.
The Daugirdas#2 formula was applied considering that
the arteriovenous (AV) gradient was near closed when
the postdialysis sample was drawn. In light of the AV
gradient closing around two minutes after the end of the
HD session [17, 30], the assumption must carry a small
error in group 1, where BUN2 was measured only one
minute (s = 1 min) after the end of the session. This
methodology pursues the rejection of methods that have
a high sensitivity to s .
Regarding the methods with computational require-
ments, the study has been focused on those based on the
single-pool model. We have evaluated the spUKM from
Sargent and Gotch [41], the nspUKM [31], and a vari-
ant of this one named nspUKM2m that does not require
BUN3 [31]. The models were solved by means of the two-
BUN method in agreement with the clinical stability of
the patients selected for the study.
The way in which the renal residual component of Kt/V
is subtracted from the overall Kt/V is described in the
Appendix.
Statistical analysis
We have used paired Student t tests to compare
the Kt/V values estimated by the evaluated methods to
the target Kt/V values measured by reference methods.
The accuracy has been quantified by means of the lim-
its of agreement (mean ± 2·SD of the paired differences,
SD being the standard deviation) according to Bland and
Altman [48]. We present scatter plots relating differences
versus averages, 95% confidence intervals for mean and
2·SD of the differences, and standard skewness and kur-
tosis parameters, for the best methods. The statistical sig-
nificance of the null hypothesis “mean of the difference
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Fig. 2. Bland-Altman plot comparing eKt/V to mKt/V. The indices
have been measured by means of the reference methods for all the
patients of the clinical study. As shown, the value of eKt/V is always
below the associated value of mKt/V, and the difference between them
increases with the dialysis dose.
equal to zero” is presented when it is necessary. The level
of statistical significance was taken as a = 0.05.
The sensitivity of the measurements was calculated by
the intergroup sensitivity parameter, SM, defined as:
v − vr = SM · max(|v | , |vr |), (2)
where vr and v refer to the homologous sample statistics
(mean or SD of the differences) of the group that is taken
as reference (group 1) and the other ones (groups 2 or 3),
respectively. An absolute value of SM below 1 indicates
that the method has little sensitivity to the variation of s ,
diuresis, and intergroup variation.
RESULTS
Figure 2 shows the scatter plot of percent differences
between the two target indices, eKt/V and mKt/V, cal-
culated by the reference methods as indicated in the
Methods section. As seen, the difference eKt/V–mKt/V
is always negative, and its absolute value increases with
the average 1/2·(eKt/V+mKt/V). This result supports the
hypothesis concerning the importance of measuring both
indices in clinical environment. The increase of the dif-
ference mKt/V–eKt/V with dialysis dose is related to the
increase of weight of the mechanisms involved in the dis-
equilibrium of solutes through body pools (Fig. 1). This
finding confirms the conclusions of an analytical compari-
son among mKt/V, eKt/V, and spKt/V presented in Prado
et al [31]. The limits of agreement between these indices
for the whole of the patients were −9.54 ± 8.45%, proving
that eKt/V significantly undervalues mKt/V (P < 10−5).
Table 3 shows the limits of agreement obtained for the
whole of the patients engaged in the clinical study for all
Table 3. Limits of agreement (mean ± 2·SD of percent differences)
of the evaluated methods with respect to the target Kt/Vs
Method mKt/V eKt/V
spUKM −0.25 ± 3.81 0 a
nspUKM −0.08 ± 0.58 –
nspUKM2m −0.03 ± 1.44 –
Lowrie#1 −15.87 ± 6.58 −17.50 ± 6.20
Jindal#1 9.38 ± 22.14 6.05 ± 27.65
Barth#1 6.25 ± 13.73 5.85 ± 13.85
Calzavara#1 −23.62 ± 8.27 −23.64 ± 5.92
Keshaviah#1 −2.23 ± 7.65 −4.11 ± 7.21
Basile#1 −4.81 ± 13.64 −3.45 ± 9.67
Ijely#1 −7.82 ± 18.13 −4.97 ± 13.75
Kerr#1 −2.66 ± 29.61 −7.93 ± 36.79
Daugirdas#1 −0.89 ± 3.87 −2.42 ± 1.05
Prado#1 −1.65 ± 1.26 –
Prado#2 −1.93 ± 2.09 –
Daugirdas#2 b – −1.74 ± 7.91
Tattersall#1 – −3.90 ± 7.77
aThe spUKM is used as reference method for measuring eKt/V (see text).
bThe spUKM uses Daugirdas#1(BUN1, BUN2 ) to calculate an estimate of
the spKt/V input.
the methods presented in Table 2. The following subsec-
tions analyze these results to give response to the question
regarding which are the best methods for measuring the
mKt/V and eKt/V.
Best methods for measuring mKt/V
According to the first column of Table 3, the nspUKM
is the most accurate measuring method for mKt/V among
all of the evaluated methods. Its scatter plot is presented
in Figure 3A. The maximum dispersion is below −0.7%
and, hence, the increment of dispersion with the dialysis
dose is negligible. The limits of agreement are very nar-
row (<0.6%), in agreement with a previous study carried
out over 30 stable ESRD patients [31]. The 95% con-
fidence intervals for mean and 2·SD of differences were
−0.08 ± 0.058% and (0.506, 0.671), respectively. The stan-
dard skewness and kurtosis parameters were 2.58 and
3.17, respectively, confirming the validity of the normal-
ity hypothesis and thus the accuracy of the 2·SD confi-
dence interval. The sensitivity, SM, of mean and SD was
−0.58 and −0.12, respectively, for group 2 with respect
to group 1. The homologous values for group 3 were 1.55
and 0.30, respectively. These outcomes confirm the pre-
dictive capacity and accuracy of the nspUKM, which can
be performed when BUN3 is available and nephrologists
have access to a computer where the iterative method
could be solved.
When BUN3 is not available, Table 3 points to both
spUKM and nspUKM2m as the best methods for mea-
suring mKt/V. The two methods present similar excellent
limits of agreement, although the limits of nspUKM2m are
slightly narrower than the limits of spUKM. At this point,
a more detailed knowledge of their behavior is necessary,
such as is provided by their scatter plots.
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Fig. 3. Bland-Altman plots comparing mKt/V estimates (mKt/Vest) computed by nspUKM (A), nspUKM2m (B), Prado#1 (C), and Prado#2 (D),
to the reference mKt/V measured by the 2pUKM model, for all the patients of the clinical study. The bottom diagrams (E) and (F) compare the
spKt/V calculated by spUKM(BUN1, BUN2 ), and the spKt/V estimate (spKt/Vest) calculated with Daugirdas#1(BUN1, BUN2 ), respectively,
against the reference mKt/V. The Kt/V obtained by Daugirdas#1(BUN1, BUN2 ) has been called spKt/Vest to emphasize that this method was
designed to approximate the solution given by spUKM(BUN1, BUN2 ).
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Table 4. Best methods for measuring Kt/V and limits of agreement (mean ± 2·SD of percent differences), as a function of the target Kt/V and the
available resources
mKt/V Iterative Non-iterative
BUN3 available nspUKM (−0.08 ± 0.58%) Prado#1 (−1.65 ± 1.26%)
BUN3 nonavailable nspUKM2m (−0.03 ± 1.44%) Prado#2 (−1.93 ± 2.09%)
eKt/V
BUN3 available spUKM(BUN1, BUN3) (0)a Daugirdas#1(BUN1, BUN3 ) (−2.42 ± 1.05%)
BUN3 nonavailable – Daugirdas#2b (−1.74 ± 7.91%)
aThis is used as a reference method for measuring eKt/V.
bThe spUKM uses Daugirdas#1(BUN1, BUN2 ) to estimate the spKt/V input. The shading intensity of cells is related to the accuracy of the method for each target
Kt/V. Accuracy increases towards top-left corners and decreases towards right-bottom corners.
Figure 3E shows the difference between the spKt/V
provided by spUKM (BUN1, BUN2) and the reference
mKt/V, for the whole of the patients. As seen, the de-
viation of spKt/V is strongly correlated to the average
dialysis dose, being negative for an average dialysis dose
above 1.3 and vice versa. In contrast, the scatter plot
of nspUKM2m presented in Figure 3B indicates that
this method is not correlated with the measured vari-
able, mKt/V. Accordingly, we selected the nspUKM2m
as the best one when BUN3 is not available. It shows
a slight increase in the absolute error for very low or
very high dialysis doses, partly due to the errors associ-
ated to Daugirdas#2 formula [27], which is used internally
by nspUKM2m to predict BUN3 (see Appendix). Confi-
dence intervals for mean and 2·SD of the differences were
−0.033 ± 0.145% and (1.267, 1.681), respectively. The
standard skewness and kurtosis parameters of the dif-
ferences distribution were −0.05 and 3.78, respectively,
which confirms the validity of the 2·SD confidence inter-
val. The sensitivity, SM, of mean and 2·SD was 1.21 and
0.11 (group 2) and 0.75 and 0.08 (group 3), respectively,
confirming the stability of the method nspUKM2m with
respect to variations in s , residual diuresis, and intergroup
variability.
In clinical environments where computers are not ac-
cessible, iterative models cannot be executed. As shown
in Table 3, only six non-iterative formulas keep the error
bands (2·SD) below 10%. From highest to lowest error
bands, these are Calzavara#1 with 8.27%, Keshaviah#1
with 7.65%, Lowrie#1 with 6.58%, Daugirdas#1 with
3.87%, Prado#2 with 2.09% and, finally, Prado#1 with
1.26%. The last three formulas, Daugirdas#1, Prado#2,
and Prado#1, are much more accurate than the first
three ones. Among these, Daugirdas#1 presents an error
strongly correlated to mKt/V, as was shown with spUKM
(see Fig. 3F). This behavior confirms the high accuracy
of the second generation formula of Daugirdas (Dau-
girdas#1) as a shortcut formula that estimates the Kt/V
provided by spUKM [13, 14]. Accordingly, the limits of
agreement between the spKt/V estimate (spKt/Vest) cal-
culated by Daugirdas#1 (BUN1, BUN2) and the spKt/V
given by the spUKM were −0.65 ± 0.79% for the whole
of the patients.
The method Prado#2 slightly undervalued mKt/V, with
a mean deviation lower than 2%. This outcome con-
firms its accuracy as a method for measuring mKt/V (P <
0.05). The associated scatter plot (Fig. 3D) does not show
any significant correlation with the dialysis dose. Confi-
dence intervals for mean and 2·SD were −1.93 ± 0.21%
and (1.83, 2.43), respectively. The confidence interval for
2·SD must be taken with care because the standard skew-
ness and kurtosis parameters of the difference distribu-
tion were −4.39 and 10.94, respectively, much exceeding
the interval of ± 2. The predictive capacity of Prado#2
is confirmed by the low values of the sensitivity, SM, of
mean and 2·SD with respect to group 1, which were 0.17
and −0.25 for group 2 and 0.11 and −0.29 for group 3,
respectively.
The method Prado#1 is more accurate than Prado#2 ac-
cording to the limits of agreements presented in Table 3,
but it requires BUN3, unlike Prado#2. This method esti-
mates mKt/V with a high accuracy (P < 0.05). Confidence
intervals for mean and 2·SD were −1.65 ± 0.13% and
(1.11, 1.47), respectively. The standard skewness and kur-
tosis parameters were 2.18 and 2.30, validating the 2·SD
interval. The sensitivity, SM, of mean and SD with respect
to group 1 was −0.28 and −0.26 for group 2 and −0.27
and −0.07 for group 3, respectively. The Bland-Altman
scatter plot of Figure 3C confirms the good performance
of this method.
These outcomes are summarized in Table 4, which
presents the selected methods for measuring mKt/V
in clinical environments, together with their limits of
agreements.
Best methods for measuring eKt/V
In this case, the problem reduces to the compari-
son among non-iterative formulas. Daugirdas#1 (BUN1,
BUN3) was the most accurate method for measuring
eKt/V from all the evaluated non-iterative formulas that
require BUN3, as proven by the limits of agreement pre-
sented in Table 3 (−2.42 ± 1.05, P < 0.05). Confidence in-
tervals for mean and 2·SD were −2.42 ± 0.11% and (0.92,
1.22), respectively. The error distribution was not nor-
mal, according to standard skewness and kurtosis param-
eters, which were −6.51 and 16.33, respectively. Hence,
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Fig. 4. Bland-Altman plot comparing the eKt/V estimate (eKt/Vest)
calculated by Daugirdas#1(BUN1, BUN3 ) to the reference eKt/V, for
all the patients of the clinical study.
the 2·SD confidence interval must be considered with cau-
tion. The sensitivity, SM, of mean and SD was −0.005 and
−0.39 for group 2 and −0.11 and 0.37 for group 3, re-
spectively. The Bland-Altman scatter plot is presented in
Figure 4.
The formulas Daugirdas#2 and Tattersall#1 estimated
eKt/V without BUN3 with similar accuracy, in agreement
with Smye et al [47]. Their scatter plots appear in Figure 5.
However, the highest undervaluation of Tattersall#1, to-
gether with the high number of studies that confirm
the excellent accuracy of Daugirdas#2, compel to select
Daugirdas#2 as the best one according to the current
knowledge. The 95% confidence intervals for mean and
2·SD in Daugirdas#2 were 1.74 ± 0.79% and (6.94, 9.21),
respectively, with 2.20 and 0.30 as standard skewness and
kurtosis parameters. The sensitivity of mean and 2·SD
with respect to group 1 was −1.34 and −0.17 for group 2
and −1.26 and −0.06 for group 3, respectively.
Table 4 also presents the best methods for measuring
eKt/V in clinical environments as a function of the avail-
able resources, together with their limits of agreements.
Although Lowrie#1 has not been selected, it requires
a special attention due to its wide use in clinical prac-
tice. This one was the first shortcut formula derived
from the spUKM. Although it undervalues both tar-
gets around 16%, it presents the lowest dispersion (SD
<3.5%) among the nonselected methods (see Table 3).
Figure 6 shows the scatter plots of Lowrie#1 with respect
to the targets eKt/V and mKt/V. Confidence intervals of
mean and 2·SD were −17.50 ± 0.62% and (5.44, 7.22) for
eKt/V, and −15.87 ± 0.66% and (5.77, 7.66) for mKt/V.
The standard skewness and kurtosis parameters guaran-
tee the normal distribution of errors. As a consequence,
the simple Lowrie#1 formula may be considered a valu-
able instrument when none of the selected methods are
available. It states a lower boundary for each Kt/V target
that oscillates between 80% and 90% of the true value.
The low value of SM (<0.5) guarantees the predictive ca-
pacity of this method.
DISCUSSION
First, we discuss the validity of the methodology ap-
plied in this study. A key point is the accuracy of the
methods used for measuring the reference targets, mKt/V
and eKt/V. Regarding mKt/V, several works have demon-
strated the high accuracy of two-pool urea kinetic models
for predicting the extracellular urea concentration evo-
lution during HD [15, 16]. Moreover, the methodology
adopted for solving the 2pUKM in this study has been
successfully used in a previous work [31]. The high accu-
racy of the eKt/V provided by spUKM (BUN1, BUN3)
has been verified in many studies [17, 22, 49].
We have used VT as input in kinetic models, assum-
ing that it can be taken equal to the total body water
(TBW) [30, 34], because we disposed of more accurate
data relative to TBW than to the delivered effective dial-
ysis system urea clearance, due to the difference between
in vitro and in vivo dialyzer clearances, as well as the
terms AR and CPR. This selection is different in other
classic studies that use the clearance, k, as input [13, 50].
However, this choice does not affect our outcomes be-
cause of the uniqueness and the low sensitivity of Kt/V
as a solution of kinetic models spUKM and nspUKM [9,
31]. Furthermore, VT has also been used as input in other
comparative studies [39].
We have selected Watson’s formula [38] for calculating
TBW instead of other recent anthropometric formulas,
being aware of the intrinsic inaccuracy of all the anthro-
pometric formulas [34, 35, 38, 51–53], and that the dis-
tribution volume associated with kinetic models is not
equivalent to the physiologic water volume, such as TBW
[54–56]. According to this complicated scenery, and con-
sidering that the Kt/V provided by spUKM and nspUKM
is hardly affected by minor errors in VT, we have selected
Watson’s formula as a balance between accuracy and sim-
plicity because this formula requires fewer anthropomet-
ric parameters than others’, such as Chertow’s [35] or
Chumlea’s [34], formulas.
The present study is limited to stable ESRD patients
submitted to thrice-weekly HD. The stability is a property
that is verified by the majority of prevalent ESRD pa-
tients, as could be expected since this is a chronic disease.
Although the case of nonstable maintenance dialysis pa-
tients could be considered as an extension of the present
study, we think that the computational and clinical re-
sources should not really be limitations for this type of
patients. This argument would get away the consideration
of shortcut formulas based on the three-BUN method,
such as the one developed by Bosticardo et al [57].
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Fig. 5. Bland-Altman plots comparing eKt/V estimates (eKt/Vest) calculated by Daugirdas#2 (A), and Tattersall#1 (B) to the reference eKt/V, for
all the patients of the clinical study.
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Fig. 6. Bland-Altman plots comparing eKt/V and spKt/V estimates (eKt/Vest and spKt/Vest), calculated through Lowrie#1(BUN1, BUN3 ) and
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spKt/Vest to the Kt/V calculated by means of Lowrie#1(BUN1, BUN2 ) with the aim of emphasizing that this method was designed to approximate
the solution given by spUKM(BUN1, BUN2 ).
Regarding the type of renal replacement therapy, the
thrice-weekly hemodialysis is still the most used renal re-
placement therapy all over the world. Furthermore, de-
spite that the current context is promoting the research
in more frequent and prolonged renal replacement ther-
apies, the novel Kt/V-derived indices and the associated
calculation methods that are emerging for addressing the
more frequent dialysis therapies should be taken with
caution because they have not been validated either clin-
ical or theoretically [9].
The present study has confirmed that the difference
mKt/V–eKt/V is significantly positive and increases with
the dialysis dose in a personalized manner (Fig. 2), which
reveals the influence of the mechanisms involved in the
urea disequilibrium (Fig. 1), in agreement with Prado et al
[31]. Furthermore, the study has shown that spKt/V is
very near to mKt/V for dialysis doses about 1.3, over-
values the mKt/V below 1.3, and vice versa (Fig. 3E), in
agreement with other studies [31, 58–60]. The value 1.3
for spKt/V is very close to the minimum dialysis dose rec-
ommended by the K/DOQI guidelines. These outcomes
confirm the arguments cited previously as support of the
hypothesis that states that the combined measurement
of eKt/V and mKt/V better describes the dialysis process
than the eKt/V alone. This conclusion agrees with a recent
review that addresses the role of urea kinetic modelling
in assessing the adequacy of dialysis [9].
The study points to nspUKM, nspUKM2m, Prado#1,
and Prado#2, as the most accurate blood-side methods for
measuring mKt/V in clinical conditions. As expected, the
accuracy increases with the available resources, in such a
way that band errors (± 2·SD) range from ± 2.09% for
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a non-iterative method without BUN3 (Prado#2) to ±
0.58% for an iterative method with BUN3 (nspUKM), as
shows Table 4. The best non-iterative blood-side method
for measuring eKt/V is Daugirdas#1 (BUN1, BUN3)
when BUN3 is available and Daugirdas#2 when BUN3
is not available. Table 4 summarizes all these results.
The spKt/V has been used internally by the methods
Daugirdas#2 and Tattersall#1 in this work. In turn, Dau-
girdas#2 is used internally by nspUKM2m and Prado#2,
as described in the Appendix. However, the importance
of spKt/V is even greater if we consider the possibility to
predict BUN2 starting from spKt/V and BUN1 by means
of the spUKM model. This relationship was exploited in
a novel method for assisting the nephrologists to select
the dialysis system that delivers a prescribed eKt/V dose
to a patient [32]. Accordingly, it is important to have non-
iterative methods that calculate spKt/V.
We have compared the non-iterative methods
Lowrie#1, Jindal#1, Barth#1, Calzavara#1, Keshaviah#1,
Basile#1, Ijely#1, Kerr#1, and Daugirdas#1, to the ref-
erence spKt/V provided by spUKM (BUN1, BUN2) to
know which is the best non-iterative method for mea-
suring spKt/V. We verified that those ones based on the
urea reduction ratio, URR = BUN1–BUN2)/BUN1·100
(%), yield much more error than the others, which are
based on the natural logarithm. This manner, the three
most accurate methods based on URR for measuring
spKt/V, were Calzavara#1 (BUN1, BUN2), with limits
of agreement (mean ± 2·SD) −23.62 ± 8.27%, Basile#1
(BUN1, BUN2), with −4.65 ± 10.74%, and Barth#1
(BUN1, BUN2), with 6.49 ± 12.16%. In contrast, the lim-
its of agreement with respect to spKt/V of the natural
algorithm-based formulas were −1.99 ± 6.92% for Ke-
shaviah#1 (BUN1, BUN2), −15.66 ± 5.95% for Lowrie#1
(BUN1, BUN2), and −0.65 ± 0.79% for Daugirdas#1
(BUN1, BUN2). These outcomes agree with other stud-
ies [13, 14], and they justify the selection of Daugirdas#1
for measuring spKt/V as input for Daugirdas#2 and
Tattersall#1 in this work.
The study also emphasizes the importance of the
Lowrie#1 formula as a very simple shortcut method that
provides an inferior limit of the Kt/V target (mKt/V or
eKt/V) that oscillates between 80% and 90% of the tar-
get in 95% of cases. This finding is very important in light
of this method being extensively used by physicians and,
therefore, many health records keep Daugirdas#1-based
Kt/V values as HD dose.
CONCLUSIONS
Starting from the premise that the combined measure-
ment of mKt/V and eKt/V provides more rich informa-
tion concerning the dialysis process than the eKt/V alone,
we have performed a clinical cross-sectional study of over
98 patients submitted to thrice-weekly HD with the aim
of comparing the most extended blood side methods for
measuring mKt/V and eKt/V in clinical environments.
Our outcomes have confirmed the major arguments
that support the cited premise, and have provided the
best measuring methods as a function of the target Kt/V
and the available resources. This manner, the study points
to nspUKM, nspUKM2m, Prado#1, and Prado#2, as the
most accurate blood-side methods for measuring mKt/V,
and to Daugirdas#1 and Daugirdas#2 as the most accurate
non-iterative methods for measuring eKt/V. The spKt/V
has been kept as an auxiliary index used internally by
some of the selected measuring methods.
We are now working to extend this study to nonstable
ESRD patients, as well as to other renal replacement ther-
apies. This study is part of a research line of our group
that pursues a better insight of the causal mechanisms
that underlie the hemodialysis outcomes.
APPENDIX
Clearance notation
We distinguish different clearances in the text. Their notation is sum-
marized in this section for convenience.
The equilibrated clearance, ek, is the clearance needed to remove
from a well-stirred pool with volume VT, and during a time equal to
the session duration, T, the same urea mass removed from the patient.
It verifies ek = eKt/V·VT /T. The single-pool clearance, spk, is simply
defined as the clearance provided by the single pool urea kinetic model,
spUKM, using BUN1 and BUN2 as boundary conditions. It verifies
spk = spKt/V·VT /T.
The effective dialysis system clearance, km, is equal to kds, kAR ds, or
kAR,CPR ds, as a function of the kinetic mechanisms considered (point
of view), as shown in Figure 1. The choice of a point of view can be
performed by means of the time that goes by from the end of dialysis
to the postdialysis blood extraction instant, s [17, 30]. It verifies km =
mKt/V·VT /T.
We use the terms k and Kt/V in the text for referring to values that are
not assigned yet. This is the case for the clearance, k, of a single-pool
kinetic model, whose value will depend on the BUNs and remaining
parameters used as input. For example, using the notation defined in
the Methods section, spUKM(BUN1, BUN2 ) gives k = spk, whereas
spUKM(BUN1, BUN3 ) gives k = ek, as detailed in the following sub-
sections.
We differentiate the true value of Kt/V from their estimations by
means of the superscript est. This way mKt/V, eKt/V, and spKt/V ap-
ply to the true values of these indices. In this work we assume that
the reference methods, 2pUKM, the spUKM(BUN1, BUN3 ), and
spUKM(BUN1, BUN2 ), are able to measure these true values, re-
spectively, whereas the evaluated methods calculate estimates to these
ones. However, we are aware that the reference methods are indirect
measuring methods that carry a small error. Accordingly, we use the
Bland-Altman statistical methodology in this comparison study [48].
Two-pool urea kinetic model
The 2pUKM describes the urea kinetic into the accessible and nonac-
cessible urea distribution compartments, by means of the following dif-
ferential equations:
X˙1(t) = −(km + Kur )c1(t) + Kc(c2(t) − c1(t)) + G
X˙2(t) = −Kc(c2(t) − c1(t)),
(3)
where t is time, X1 and X2 are accessible and nonaccessible compart-
ment urea nitrogen masses, respectively, which are related to urea ni-
trogen concentrations by c1 (t) = X1 (t)/V1 (t) and c2 (t) = X2 (t)/V2
(t). Compartmental urea distribution volumes are given by V1 (t) = fv1
V(t) and V2 (t) = (1-fv1 )V(t), V(t) being the total urea distribution
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volume and fv1 the fraction of volume into the accessible compartment.
The total volume V(t) follows the equation V(t) = VT + Qf ·(T−t)
during the HD session, Qf being the ultrafiltrated flow rate, QUF, plus
the urine flow rate Qu.
The 2pUKM, defined by Equation 3, differs from the 2pUKM used
by Canaud et al [15] in the presence of the renal residual urea clearance
term, Kur. The influence of the intercompartmental water transport on
the value of mKt/V solved from Equation 3 is negligible [31].
This model is solved iteratively following the approach described in
the Methods section, to obtain the value of the effective dialysis system
urea clearance, km, which will be equal to kds, kAR ds, or kAR,CPR ds
(Fig. 1), as a function of the time that goes by from the end of dialysis
to the postdialysis blood extraction instant, s .
Single-pool urea kinetic models
This subsection presents the analytical solutions and mathematical
procedures used to solve the single-pool urea kinetic models. The urea
nitrogen concentration, c, provided by nspUKM and spUKM, is given
by the following equation:
c(t, ) = Gˆ
(kˆ + bˆ) +
(
c(0) − Gˆ
(kˆ + bˆ)
)
·
(
V(0) + bˆt
V(0)
)−(kˆ+bˆ)/bˆ
(4)
where  = (c(0), kˆ, bˆ, Gˆ, V(0))is a parameter vector.
The arguments of  are the initial value of urea nitrogen concen-
tration, the urea clearance, the slope of urea distribution volume, the
urea nitrogen generation rate, and the initial value of the urea distribu-
tion volume, respectively. The parameters covered with a hat acquire
different values at inter- and intradialysis periods, as indicated below.
We can assume that the urea nitrogen concentration performs in a
weekly periodic manner in stable patients submitted to thrice-weekly
HD. Denoting p as the duration of a week, the condition of periodicity
can be written as c(0) = c(p). This classic assumption yields the two-
BUN method [61]. Using Equation 4 with  = (c(0), kˆ, bˆ, Gˆ, V(0))
specified for inter- and intradialysis periods, under the two-BUN
method, the following iterative equation system is obtained [31]:
c(TSP, C01, k, −Qf TTSP , G
T
TSP
, VT + Qf T) = CT1
c(h1, CT1, Kur , Qf
T
h1
, G, VT) = BUN1
c(TSP, BUN1, k, −Qf TTSP , G
T
TSP
, VT + Qf T) = CT2(G)
c(h2, CT2(G), Kur , Qf
T
h2
, G, VT) = C03
c(TSP, C03, k, −Qf TTSP , G
T
TSP
, VT + Qf T) = CT3
c(h3, CT3, Kur , Qf
T
h3
, G, VT) = C01,
(5)
where C0i and CTi are, respectively, the single-pool predialysis and post-
dialysis urea nitrogen concentrations of the three sessions delivered
during a week (i.e., i = 1, 2, 3). The interdialysis period following the
session i is designated as h i, and TSP is the session duration assigned
to the model. System (Equation 5) is solved to give C01, CT1, C03, and
CT3, together with the parameters G and k. The other variables are
inputs to the model that have been defined above. Specifically, VT is
calculated as the TBW from the Watson’s formula, which is written here
for convenience:
(males) TBW = 2.447 − 0.09516Y + 0.1074H + 0.3362 W
(females) TBW = −2.097 + 0.1069H + 0.2466 W, (6)
where TBW is in liters (L), Y is the age of the patient (years), H is the
height (cm), and W is the dry weight (kg). The latter refers to the weight
of the patient without edema, and is considered equal to the postdialysis
weight.
In the case of the nspUKM model, the parameter TSP must be cal-
culated by the following non-iterative equation [31]:
TSP = A(R, Re) · T + B(R, Re) · tequ
A(R, Re) =
(Re − R) ln(Re) + wa
1 − Re
B(R, Re) = ln(Re)1 − Re
(
R − Re − w − (1 − R)ln(R + w )
) (7)
where the variables R and Re are defined as BUN2 /BUN1 and
BUN3 /BUN1, respectively. The variable w is defined as w =
Re(R
a(tequ/T−1)
e − 1), and a = −0.9664 ln(Re) + 0.8984 ln(R) + 0.9825.
The value of CT2 in Equation 5 is related to G, as indicated [49]:
CT2(G) = BUN3
VT + Qf T
h2
tequ
VT
− Gtequ
VT
(8)
Equation 8 guarantees that c(T+tequ ) = BUN3. The two-BUN
nspUKM method is given by Equations 5, 7, and 8. Once k is obtained,
the mKt/V estimate is calculated as mKt/Vest = kT/VT –Kur T/VT.
The two-BUN spUKM(BUN1, BUN3 ) method can be considered
a particular case of Equation 5, such that TSP = T [31]. It provides
the equilibrated clearance as solution for k; therefore, the eKt/V used
as reference in this study is calculated as eKt/V = kT/VT –Kur T/VT,
where k is solved from Equations 5 and 8 with TSP = T.
The nspUKM and nspUKM(BUN1, BUN3 ) provide the same so-
lution for the urea generation rate, G. This value is a very accurate
estimate of the patient average urea nitrogen generation rate [15, 31,
39] and, hence, it has been used as input for the 2pUKM.
The spUKM(BUN1, BUN2 ) refers to the use of the spUKM model
with BUN2 as boundary condition at t = T, as was applied in the NCDS
study. Hence, this method is defined by the system Equation 5, where
CT2 (G) is substituted by BUN2 in the third equation, and TSP = T [31].
Once k is obtained, the value of spKt/V is given by spKt/V = kT/VT
–Kur T/VT.
The nspUKM2m is a nspUKM-based iterative method for measuring
mKt/V that substitutes BUN3 by an estimate, BUN3 est [31]. The latter
is obtained solving Equation 5 with TSP = T and the rules of k and CT2
interchanged, that is, taking k as input parameter and CT2 as output
parameter. The value of k that must be used as input is calculated by
Equation 9 if the AV gradient induced by the HD session can be ne-
glected when the postdialysis blood sample is drawn (i.e., arterial access
with closed AV gradient or venous access [30]).
k = VT
T
((
− ln(R − 0.008 T
60
) + (4 − 3.5R) Qf T
VT
· 0.55
)
·(1 − 0.47 60
T
) + 0.02
) (9)
If the AV access is arterial and the AV gradient is full, then the value
of k that must be used as input will be given by the following equation:
k = VT
T
((
− ln(R − 0.008 T
60
) + (4 − 3.5R) Qf T
VT
· 0.55
)
·(1 − 0.6 60
T
) + 0.03
) (10)
Equations 9 and 10 come from the second generation formula of
Daugirdas [12] and the rate equation of Daugirdas and Schneditz [27].
The method nspUKM2m was validated in [31]. In these equations, T is
in minutes (min), VT is in liters (L), and the total leaving flow rate, Qf,
is in L/min.
Non-iterative methods
This section presents all the non-iterative methods evaluated in this
study, sorted according to Table 2. We follow the notation defined in
the Methods section. The methods collected by Movilli are presented
first [40].
Lowrie#1 formula:
Kt/V = ln(C0/CT) (11)
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Jindal#1 formula:
Kt/V = 0.04 ((C0 − CT)/C0 · 100) − 1.2 (12)
Barth#1 formula:
Kt/V = 0.031 ((C0 − CT)/C0 · 100) − 0.66 (13)
Calzavara#1 formula:
Kt/V = (C0 − CT)/ ((C0 + CT)/2) (14)
Keshaviah#1 formula:
Kt/V = 1.162 ln(C0/CT) (15)
Basile#1 formula:
Kt/V = 0.023 ((C0 − CT)/C0 · 100) − 0.284 (16)
Ijely#1 formula:
Kt/V = 0.018 ((C0 − CT)/C0 · 100) (17)
Kerr#1 formula:
Kt/V = 0.042 ((C0 − CT)/C0 · 100) − 1.48 (18)
Daugirdas#1 formula:
Kt/V = − ln(CT/C0 − 0.008T/60) + 0.55(4 − 3.5CT/C0)Qf T/VT
(19)
The value of the fractional renal residual clearance (Kur T/VT ) must
be subtracted from the total Kt/V in Equations 11 to 19 for obtaining
the desired Kt/V. The initial urea concentration, C0, is equal to the
predialysis BUN (BUN1 ), whereas the final urea concentration, CT, is
equal to the postdialysis BUN (BUN2 ) if Kt/V is spKt/Vest (which is in
turn used as an estimate of mKt/V as indicated in the Methods section),
and to the rebound BUN (BUN3 ) if Kt/V is eKt/Vest. In Equation 19,
T is in min, VT is in L, and Qf is in L/min.
Prado#1 was developed as a generalization of the second genera-
tion formula of Daugirdas [12], with the aim of estimating the mKt/V
calculated by the nspUKM [31]. It can be written as follows:
mKt/Vest = T
TSP
(
− ln
(
BUN3
BUN1
− 0.008T
2
60TSP
)
+
(
4 − 3.5 BUN3
BUN1
)
Qf T
VT
· 0.55
)
− Kur T
VT
,
(20)
where TSP is calculated using Equation 7.
Prado#2 is an extension of Prado#1 that substitutes BUN3 by an
estimate, BUN3 est. This value is calculated through Equation 4 as:
BUNest3 =
n
p VTBUN1
(
1 − eeKt/Vest
)
ekest − Qf ·
(
VT
V(0)
) (ekest −Q f )
Q f
+ BUN1
(
VT
V(0)
) (ekest −Q f )
Q f
,
(21)
where n = 3 for thrice-weekly HD and the urea generation rate has
been estimated considering c(0) = c(p), in agreement with the two-
BUN method. The equilibrated clearance estimate, ekest, is calculated
by means of Equations 9 or 10, as a function of the AV gradient state
at the postdialysis instant, and eKt/Vest = ekestT/VT.
Daugirdas#2 is given by the following equations:
eKt/Vest = spKt/V
(
1 − 0.6 60T
)
+ 0.03
eKt/Vest = spKt/V
(
1 − 0.47 60T
)
+ 0.02,
(22)
where T is in minutes. The first and second equation of 22 are applied
under the same conditions of Equations 10 and 9, respectively [30].
Tattersall#1 is given by:
eKt/Vest = spKt/V T
T + tp , (23)
being tp = 35 minutes.
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